DGAP-News: Competitive Technologies– Management Team Emphasized Continued Profitable Growth Plans At Annual Shareholder Meeting

Competitive Technologies, Inc.

02.05.2011 20:13
—————————————————————————

FAIRFIELD, Conn., 2011-05-02 20:12 CEST (GLOBE NEWSWIRE) —
Competitive Technologies Inc. (OTCQX:CTTC) held its annual meeting of
shareholders earlier today at the Norwalk Inn and Conference Center in Norwalk,
Conn. CTTC–s Chairman, William Reali reviewed the company–s performance and the
management team of Mr. Reali, CEO Johnnie D. Johnson and EVP Aris Despo
provided highlights of the company–s sales plan for its Calmare(r) pain therapy
medical device. Emphasizing the company–s team approach, Mr. Johnson read
supportive remarks provided by Professor Giuseppe Marineo, inventor of the
–Scrambler Therapy– technology underlying the Calmare(r) device. S.B. Oh, EVP of
GEOMC Co., Ltd. of Korea, which manufactures the Calmare(r) device for CTTC
attended the meeting, also showing support of CTTC–s plans.

At the meeting, CTTC shareholders re-elected the company–s four sitting
directors, including Mr. Reali, Joel M. Evans, MD, Richard D. Hornidge, and
Rustin Howard. In addition, shareholders ratified the appointment of Mayer
Hoffman McCann CPAs as CTTC–s independent public accounting firm.

Anticipated revenues for the first quarter of 2011 will primarily be from the
sale of 72 Calmare(r) devices with a gross value of $1.9 million, of which CTTC–s
share is approximately one half. Anticipated benefits from the company–s other
technologies, including bone cement, homocysteine assays, sexual dysfunction,
RFID, and specimen cups, were also discussed. A copy of the presentation can be
found under the –Investors– tab at the CTTC website: www.competitivetech.net.

–Competitive Technologies remains confident that it will be profitable
throughout the fiscal year ending December 31, 2011,– said Mr. Johnson. –The
management team is committed to moving this company forward and focusing on
building revenues. At the forefront of our activities this year is enabling
Prof. Marineo–s –Scrambler Therapy– to help more physicians relieve their
patients– neuropathic pain. As sales of the Calmare(r) device expand, we expect
revenue and net profit to grow.–

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, provides distribution, patent
and technology transfer, sales and licensing services focused on the needs of
its customers and matching those requirements with commercially viable product
or technology solutions. CTTC is a global leader in identifying, developing and
commercializing innovative products and technologies. CTTC–s principal
technology is the non-invasive Calmare(r) pain therapy medical device, which uses
the biophysical –Scrambler Therapy– technology, and was developed in Italy by
CTTC–s client, Professor Giuseppe Marineo. The Calmare(r) device is currently
being manufactured for sale by CTTC–s partner, GEOMC Co., Ltd. of Seoul, Korea.
For more information on the device, visit www.calmarett.com. Visit CTTC–s
website: www.competitivetech.net

Statements made about our future expectations are forward-looking statements
and subject to risks and uncertainties as described in our most recent Annual
Report on Form 10-K for the year ended July 31, 2010, filed with the SEC on
October 27, 2010, and other filings with the SEC, and are subject to change at
any time. Our actual results could differ materially from these forward-looking
statements. We undertake no obligation to update publicly any forward-looking
statement.

CONTACT: Jean Wilczynski, IR Services, LLC
(860.434.2465/info@corpirservices.com)
News Source: NASDAQ OMX

02.05.2011 Dissemination of a Corporate News, transmitted by DGAP –
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP–s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

—————————————————————————

Language: English
Company: Competitive Technologies, Inc.

United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US2045121074
WKN:

End of Announcement DGAP News-Service

—————————————————————————